An Open-label, Single Arm, Phase III Clinical Study to Evaluate the Efficacy and Safety of CJ Smallpox Vaccine in Vaccinia-naive Healthy Volunteers.
Phase of Trial: Phase III
Latest Information Update: 18 Jun 2014
At a glance
- Drugs CJ 50300 (Primary)
- Indications Smallpox
- Focus Adverse reactions; Pharmacodynamics
- 02 Aug 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 02 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Feb 2010 New trial record